HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced that new clinical data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback